These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8430127)

  • 1. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.
    Layer RT; Kaddis FG; Wallace LJ
    Pharmacol Biochem Behav; 1993 Jan; 44(1):245-7. PubMed ID: 8430127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats.
    Hoffman DC
    Pharmacol Biochem Behav; 1994 Apr; 47(4):907-12. PubMed ID: 8029261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization.
    Tzschentke TM; Schmidt WJ
    Behav Brain Res; 1997 Mar; 84(1-2):99-107. PubMed ID: 9079776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.
    Tzschentke TM; Schmidt WJ
    Neurosci Lett; 1995 Jun; 193(1):37-40. PubMed ID: 7566661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated treatment with the NMDA antagonist MK-801 disrupts reconsolidation of memory for amphetamine-conditioned place preference.
    Sadler R; Herzig V; Schmidt WJ
    Behav Pharmacol; 2007 Nov; 18(7):699-703. PubMed ID: 17912055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
    Irifune M; Shimizu T; Nomoto M; Fukuda T
    Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.
    Stewart J; Druhan JP
    Psychopharmacology (Berl); 1993; 110(1-2):125-32. PubMed ID: 7870871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rewarding properties of NMDA and MK-801 (dizocilpine) as indexed by the conditioned place preference paradigm.
    Panos JJ; Rademacher DJ; Renner SL; Steinpreis RE
    Pharmacol Biochem Behav; 1999 Nov; 64(3):591-5. PubMed ID: 10548276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dizocilpine [(+)-MK-801] on the expression of associative and non-associative sensitization to D-amphetamine.
    Grönig M; Atalla A; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):228-31. PubMed ID: 14673514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats.
    Biondo AM; Clements RL; Hayes DJ; Eshpeter B; Greenshaw AJ
    Psychopharmacology (Berl); 2005 Apr; 179(1):189-97. PubMed ID: 15744543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference.
    Zarrindast MR; Lashgari R; Rezayof A; Motamedi F; Nazari-Serenjeh F
    Eur J Pharmacol; 2007 Jul; 568(1-3):192-8. PubMed ID: 17509561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
    Thompson LT; Disterhoft JF
    J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
    Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
    Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning.
    Gould TJ; McCarthy MM; Keith RA
    Behav Pharmacol; 2002 Jul; 13(4):287-94. PubMed ID: 12218509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
    Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice.
    Okuyama S; Imagawa Y; Tomisawa K
    Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine.
    Wolf ME; Khansa MR
    Brain Res; 1991 Oct; 562(1):164-8. PubMed ID: 1839240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats.
    Ouagazzal A; Nieoullon A; Amalric M
    Psychopharmacology (Berl); 1993; 111(4):427-34. PubMed ID: 7870984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditioned increase in place preference by access to novel objects: antagonism by MK-801.
    Bevins RA; Bardo MT
    Behav Brain Res; 1999 Feb; 99(1):53-60. PubMed ID: 10512572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.